In silico models of cancer

Wiley Interdisciplinary Reviews: Systems Biology and Medicine

Volumn 2, Issue 4, 2010, Pages 438-459

  Edelman, Lucas B ^a   Eddy, James A ^a   Price, Nathan D ^b  

^a University of Illinois at Urbana Champaign   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BIOLOGICAL MODEL; BIOLOGY; COMPUTER SIMULATION; HUMAN; METHODOLOGY; NEOPLASM; REVIEW; STATISTICAL MODEL;

ANIMALS; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; HUMANS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; NEOPLASMS;

EID: 79952114337     PISSN: 19395094     EISSN: 1939005X     Source Type: Journal    
DOI: 10.1002/wsbm.75     Document Type: Review

References (219)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000, 100:57-70.
2. Land H, Parada LF, Weinberg RA. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 1983, 304:596-602.
3. Lloyd AC, Obermuller F, Staddon S, Barth CF, McMahon M, et al. Cooperating oncogenes convergeto regulate cyclin/cdk complexes. Genes Dev 1997, 11:663-677.
4. Fanidi A, Harrington EA, Evan GI. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 1992, 359:554-556.
5. Lowe SW, Cepero E, Evan G. Intrinsic tumour suppression. Nature 2004, 432:307-315.
6. McMurray HR, Sampson ER, Compitello G, Kinsey C, Newman L, et al. Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype. Nature 2008, 453:1112.
7. Chuang HY, Lee E, Liu YT, LeeD, Ideker T.Networkbased classification of breast cancer metastasis. Mol Syst Biol 2007, 3:140.
8. Liu ET, Lemberger T. Higher order structure in the cancer transcriptome and systems medicine. Mol Syst. Biol 2007, 3:94.
9. Auffray C. Protein subnetwork markers improve prediction of cancer outcome. Mol Syst Biol 2007, 3:141.
10. Neely KE, Workman JL. The complexity of chromatin remodeling and its links to cancer. Biochim Biophys Acta 2002, 1603:19-29.
11. Seligson DB, Horvath S, Shi T, Yu H, Tze S, et al. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 2005, 435:1262.
12. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. DNA 2007, 1:E1.
13. Jones PA. DNA methylation and cancer. Oncogene 2002, 21:5358-5360.
14. Esteller M, Fraga MF, Paz MF, Campo E, Colomer D, et al. Cancer epigenetics and methylation. Science 2002, 297:1807-1808.
15. Laird PW. Cancer epigenetics. Hum. Mol. Genet 2005, 14:65-76.
16. Tang Y, Nakada MT, Kesavan P, McCabe F, Millar H, et al. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Cancer Res 2005, 65:3193-3199.
17. Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006, 124:263-266.
18. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006, 66:605-612.
19. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006, 6:392-401.
20. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004, 432:332-337.
21. Sheu BC, Chang WC, Cheng CY, Lin HH, Chang DY, et al. Cytokine regulation networks in the cancer microenvironment. Front Biosci 2008, 13:6255-6268.
22. De Luca A, Carotenuto A, Rachiglio A, Gallo M, Maiello MR, et al. The role of the EGFR signaling in tumor microenvironment. J Cell Physiol 2008, 214:559-567.
23. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, et al. Molecular characterization of the tumormicroenvironment in breast cancer. Cancer Cell 2004, 6:17-32.
24. Smallbone K, Gavaghan DJ, Gatenby RA, Maini PK. The role of acidity in solid tumour growth and invasion. J Theor Biol 2005, 235:476-484.
25. Smallbone K, Gatenby RA, Gillies RJ, Maini PK, Gavaghan DJ. Metabolic changes during carcinogenesis: potential impact on invasiveness. J Theor Biol 2007, 244:703-713.
26. Gajewski TF, Meng Y, Harlin H. Immune suppression in the tumor microenvironment. J Immunother 2006, 29:233-240.
27. Gajewski TF, Meng Y, Blank C, Brown I, Kacha A, et al. Immune resistance orchestrated by the tumor microenvironment. Immunol Rev 2006, 213:131-145.
28. Croci DO, Zacaŕi{dotless}as Fluck MF, Rico MJ, Matar P, Rabinovich GA, et al. Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment. Cancer Immunol Immunother 2007, 56:1687-1700.
29. Laakkonen P, Waltari M, Holopainen T, Takahashi T, Pytowski B, et al. Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth. Cancer Res 2007, 67:593.
30. Su JL, Yen CJ, Chen PS, Chuang SE, Hong CC, et al. The role of the VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer 2007, 96:541-545.
31. Hirakawa S, Brown LF, Kodama S, Paavonen K, Alitalo K, et al. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 2007, 109:1010-1017.
32. Taranawski R, Skladowski K, Swienrniaka A, Wygoda A, Mucha A. Repopulation of tumour cells during radiotherapy is doubled during treatment gaps. Computational and Mathematical Methods in Medicine 2000, 2:297-305.
33. KohandelM, Sivaloganathan S, Oza A. Mathematical modeling of ovarian cancer treatments: sequencing of surgery and chemotherapy. J Theor Biol 2006, 242:62-68.
34. Verschraegen C, Vinh-Hung V, Cserni G, Gordon R, Royce ME, et al. Modeling the effect of tumor size in early breast cancer. Ann Surg 2005, 241:309-318.
35. Ayati BP, Webb GF, Anderson ARA. Computational methods and results for structured multiscale models of tumor invasion. Multiscale Modeling and Simulation 2006, 5:1-120
36. Nordling CO. A new theory on cancer-inducingmechanism. Br J Cancer 1953, 7:68-72.
37. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, et al. Initial Sequencing and Analysis of the Human Genome 2001, 409:860-921.
38. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, et al. The sequence of the human genome. Science 2001, 291:1304-1351.
39. Parsons DW, Jones S, Zhang X, Lin JCH, Leary RJ, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008, 321:1807-1812.
40. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006, 314:268-274.
41. Nevins JR, Potti A. Mining gene expression profiles: expression signatures as cancer phenotypes. Nat Rev Genet 2007, 8:601-609.
42. Coe BP, Chari R, Lockwood WW, Lam WL. Evolving strategies for global gene expression analysis of cancer. J Cell Physiol 2008, 217:590-597.
43. Allison DB, Cui X, Page GP, Sabripour M. Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet 2006, 7:55-65.
44. Mardis ER. The impact of next-generation sequencing technology on genetics. Trends Genet 2008, 24:133-141.
45. Shendure J, Ji H. Next-generation DNA sequencing. Nat Biotechnol 2008, 26:1135-1145.
46. Gingras AC, Gstaiger M, Raught B, Aebersold R. Analysis of protein complexes using mass spectrometry. Nat Rev Mol Cell Biol 2007, 8:645-654.
47. Cox J, Mann M. Is proteomics the new genomics? Cell 2007, 130:395-398.
48. Bantscheff M, Schirle M, Sweetman G, Rick J, Kuster B. Quantitative mass spectrometry in proteomics: a critical review. Anal Bioanal Chem 2007, 389:1017-1031.
49. Vienna A, GmbH EB, Linz KHE, Linz A, Innsbruck A. Transforming omics data into context: bioinformatics on genomics and proteomics raw data. Electrophoresis 2006, 27:2659-2675.
50. Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002, 30:207-210.
51. Sherlock G, Hernandez-Boussard T, Kasarskis A, Binkley G, Matese JC, et al. The stanford microarray database. Nucleic Acids Res 2001, 29:152-155.
52. Perier RC, Junier T, Bucher P. The eukaryotic promoter database EPD. Nucleic Acids Res 1998, 26:353-357.
53. Zhao F, Xuan Z, Liu L, Zhang MQ. TRED: a Transcriptional Regulatory Element Database and a platform for in silico gene regulation studies. Nucleic Acids Res 2005, 33:D103-D107.
54. Martens L, Hermjakob H, Jones P, Adamski M, Taylor C. PRIDE: the proteomics identifications database. Proteomics 2005, 5:3537-3545.
55. Camon E, Magrane M, Barrell D, Lee V, Dimmer E, et al. The Gene Ontology Annotation (GOA) Database: sharing knowledge in uniprot with gene ontology. Nucleic Acids Res 2004, 32:W313-W317.
56. Apweiler R, Bairoch A, Wu CH, Barker WC, Boeckmann B, et al. UniProt: the Universal Protein knowledgebase. Nucleic Acids Res 2004, 32:D115.
57. Camon E, Magrane M, Barrell D, Binns D, Fleischmann W, et al. The Gene Ontology Annotation (GOA) Project: Implementation of GO in SWISSPROT, TrEMBL, and InterPro. Genome Res 2003, 13:662-672.
58. Flicek P, Aken BL, Beal K, Ballester B, Caccamo M, et al. Ensembl 2008. Nucleic Acids Res 2008, 36(Database issue):D707-D714.
59. Sterk P, Kersey PJ, Apweiler R. Genome reviews: standardizing content and representation of information about complete genomes. OMICS: A Journal of Integrative Biology 2006, 10:114-118.
60. Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000, 28:27-30.
61. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000, 25:25-29.
62. Krieger CJ, Zhang P, Mueller LA, Wang A, Paley S, et al. MetaCyc: a multiorganism database of metabolic pathways and enzymes. Nucleic Acids Res 2004, 34(Database Issue):D511-D516.
63. Karp PD, Ouzounis CA, Moore-Kochlacs C, Goldovsky L, Kaipa P, et al. Expansion of the Bio-Cyc collection of pathway/genome databases to 160 genomes. Nucleic Acids Res 2005, 33:6083-6089.
64. DeJongh M, Formsma K, Boillot P, Gould J, Rycenga M, et al. Toward the automated generation of genome-scale metabolic networks in the SEED. BMC Bioinformatics 2007, 8:139.
65. Ren Q, Chen K, Paulsen IT. TransportDB: a comprehensive database resource for cytoplasmic membrane transport systems and outer membrane channels. Nucleic Acids Res 2006, 35:D274-D279.
66. Le Nov'ere N, Bornstein B, Broicher A, Courtot M, Donizelli M, et al. BioModels Database: a free, centralized database of curated, published, quantitative kinetic models of biochemical and cellular systems. Nucleic Acids Res 2006, 34:D689-D691.
67. Sivakumaran S, Hariharaputran S, Mishra J, Bhalla US. The database of quantitative cellular signaling: management and analysis of chemical kineticmodels of signaling networks. Bioinformatics 2003, 19:408-415.
68. Ji ZL, Chen X, Zhen CJ, Yao LX, Han LY, et al. KDBI: Kinetic Data of Bio-molecular Interactions database. Nucleic Acids Res 2003, 31: 255-257.
69. Platzer A, Perco P, Lukas A, Mayer B. Characterization of protein-interaction networks in tumors. BMC Bioinformatics 2007, 8:224.
70. Ramani AK, Bunescu RC, Mooney RJ, Marcotte EM. Consolidating the set of known human proteinprotein interactions in preparation for large-scale mapping of the human interactome. Genome Biol 2005, 6:R40.
71. Xenarios I, Salwinski L, Duan XJ, Higney P, Kim SM, et al. DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions. Nucleic Acids Res 2002, 30:303-305.
72. Zanzoni A, Montecchi-Palazzi L, Quondam M, Ausiello G, Helmer-Citterich M, et al. MINT: a Molecular INTeraction database. FEBS Lett 2002, 513:135-140.
73. Pagel P, Kovac S, Oesterheld M, Brauner B, Dunger-Kaltenbach I, et al. The MIPS mammalian proteinprotein interaction database. Bioinformatics 2005, 21:832-834.
74. Lloyd CM, Halstead MDB, Nielsen PF. CellML: its future, present and past. Prog BiophysMol Biol 2004, 85:433-450.
75. Le Nov'ere N, Finney A, Hucka M, Bhalla US, Campagne F, et al. Minimum information requested in the annotation of biochemical models (MIRIAM). Nat Biotechnol 2005, 23:1509-1515.
76. Hucka M, Finney A, Sauro HM, Bolouri H, Doyle JC, et al. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics 2003, 19:524-531.
77. Stromback L, Lambrix P. Representations of molecular pathways: an evaluation of SBML, PSI MI and BioPAX. Bioinformatics 2005, 21:4401-4407.
78. Shannon PT, Reiss DJ, Bonneau R, Baliga NS. The Gaggle: an open-source software system for integrating bioinformatics software and data sources. BMC Bioinformatics 2006, 7:176.
79. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003, 13:2498-2504.
80. KarolchikD, Kuhn RM, Baertsch R, BarberGP, Clawson H, et al. The UCSC genome browser database: 2008 update. Nucleic Acids Res 2008, 36(Database issue):D773-D779.
81. Maglott D, Ostell J, Pruitt KD, Tatusova T. Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res 2006, 33(Database issue):D54-D58.
82. Kanehisa M, Goto S, Kawashima S, Nakaya A. The KEGG databases at GenomeNet. Nucleic Acids Res 2002, 30:42-46.
83. Cusick ME, Yu H, Smolyar A, Venkatesan K, Carvunis AR, et al. Literature-Curated Protein Interaction Datasets. Nat Methods 2009, 6:39-46.
84. Taylor CF, Field D, Sansone SA, Aerts J, Apweiler R, et al. Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project. Nat Biotechnol 2008, 26:889-896.
85. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001, 29:365-371.
86. Taylor CF, Paton NW, Lilley KS, Binz PA, Julian RK et al. The minimum information about a proteomics experiment (MIAPE). Nat Biotechnol 2007, 25:887-893.
87. Venkatesan K, Rual JF, Vazquez A, Stelzl U, Lemmens I, et al. An empirical framework for binary interactome mapping. Nature Methods 2008, 6:83-90.
88. Braun P, Tasan M, Dreze M, Barrios-Rodiles M, Lemmens I, et al. An experimentally derived confidence score for binary protein-protein interactions. Nat Methods 2009, 6:91-97.
89. Quackenbush J. Microarray analysis and tumor classification. N Engl JMed 2006, 354:2463-2472.
90. Davis CA, Gerick F, Hintermair V, Friedel CC, Fundel K, et al. Reliable gene signatures for microarray classification: assessment of stability and performance. Bioinformatics 2006, 22:2356-2363.
91. de Souto MCP, Costa IG, de Araujo DSA, Ludermir TB, Schliep A. Clustering cancer gene expression data: a comparative study.BMCBioinformatics 2008, 9:497.
92. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511.
93. Bullinger L, Dohner K, Bair E, Frohling S, Schlenk RF, et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl JMed 2004, 350:1605-1616.
94. Naderi A, Teschendorff AE, Barbosa-Morais NL, Pinder SE, Green AR, et al. A gene-expression signature to predict survival in breast cancer across independent data sets. Oncogene 2006, 26:1507-1516.
95. Brown MPS, Grundy WN, Lin D, Cristianini N, Sugnet CW, et al. Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc Nat Acad Sci 2000, 97:262-267.
96. Khan J, Wei JS, Ringnér M, Saal LH, Ladanyi M, et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 2001, 7:673-679.
97. Herrero J, Valencia A, Dopazo J. A hierarchical unsupervised growing neural network for clustering gene expression patterns. Bioinformatics 2001, 17:126-136.
98. Geman D. Classifying gene expression profiles from pairwise mRNA comparisons. Stat Appl Genet Mol Biol 2004, 3.
99. Tan AC, Naiman DQ, Xu L, Winslow RL, Geman D. Simple decision rules for classifying human cancers from gene expression profiles. Bioinformatics 2005, 21:3896-3904.
100. Xu L, Geman D, Winslow RL. Large-scale integration of cancer microarray data identifies a robust common cancer signature. BMC Bioinformatics 2007, 8:275.
101. PriceND, Trent J, El-Naggar AK, Cogdell D, Taylor E, et al.Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas. Proc Nat Acad Sci 2007, 104:3414-3419.
102. Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 2007, 356:11-20.
103. Michiels S, Koscielny S, Hill C. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 2005, 365:488-492.
104. Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002, 1:133-143.
105. Foekens JA, Atkins D, Zhang Y, Sweep FC, Harbeck N, et al. Multicenter validation of a gene expression-based prognostic signature in lymph nodenegative primary breast cancer. J Clin Oncol 2006, 24:1665-1671.
106. Ayers M, Symmans WF, Stec J, Damokosh AI, Clark E, et al. Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer. J Clin Oncol 2004, 22:2284-2293.
107. Dressman HK, Hans C, Bild A, Olson JA, Rosen E, et al. Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy. Clin Cancer Res 2006, 12:819-826.
108. Thuerigen O, Schneeweiss A, Toedt G, Warnat P, Hahn M, et al. Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer. J Clin Oncol 2006, 24:1839-1845.
109. Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP. GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics 2007, 23:3251-3253.
110. Kim SY, Volsky DJ. PAGE: Parametric Analysis of Gene Set Enrichment. BMC Bioinformatics 2005, 6:144.
111. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genomewide expression profiles. Proc Nat Acad Sci 2005, 102:15545-15550.
112. Rhodes DR, Chinnaiyan AM. Integrative analysis of the cancer transcriptome. Nat Genet 2005, 37(suppl 6):S31-S37.
113. Shen R, Chinnaiyan AM, Ghosh D. Pathway analysis reveals functional convergence of gene expression profiles in breast cancer. BMC Med Genomics 2008, 1:28.
114. Tomlins SA, Mehra R, Rhodes DR, Cao X, Wang L, et al. Integrative molecular concept modeling of prostate cancer progression. Nat Genet 2006, 39:41-51.
115. Lee E, Chuang HY, Kim JW, Ideker T, Lee D. Inferring pathway activity toward precise disease classification. PLoS Comput Biol 2008, 4:e1000217.
116. Yu JX, Sieuwerts AM, Zhang Y, Martens JWM, Smid M, et al. Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer. BMC Cancer 2007, 7:182.
117. Smid M, Wang Y, Zhang Y, Sieuwerts AM, Yu J, et al. Subtypes of breast cancer show preferential site of relapse. Cancer Res 2008, 68:3108-3114.
118. Saal LH, Johansson P, Holm K, Gruvberger-Saal SK, She QB, et al. Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity. Proc Nat Acad Sci 2007, 104:7564-7569.
119. Price ND, Edelman LB, Lee I, Yoo H, Hwang D, et al. Systems biology and systems medicine. In: Ginsburg GS, Willard HF., eds. Genomic and Personalized Medicine. Amsterdam, Elservier; 2009, 74-86.
120. Hood L, Heath JR, PhelpsME, Lin B. Systems biology and new technologies enable predictive and preventative medicine. Science 2004, 306:640-643.
121. Kitano H. Systems biology: a brief overview. Science 2002, 295:1662-1664.
122. Lage K, Karlberg EO, Størling ZM, Ó lason P, Pedersen AG, et al. A human phenome-interactome network of protein complexes implicated in genetic disorders. Nat Biotechnol 2007, 25:309-316.
123. Price ND, Shmulevich I. Biochemical and statistical network models for systems biology. Curr Opin Biotechnol 2007, 18:365-370.
124. Sachs K, Perez O, Pe'er D, Lauffenburger DA, Nolan GP. Causal protein-signaling networks derived from multiparameter single-cell data. Science 2005, 308:523-529.
125. Wang RS, Wang Y, Zhang XS, Chen L. Inferring transcriptional regulatory networks from high-throughput data. Bioinformatics 2007, 23:3056-3064.
126. Bansal M, Gatta GD, di Bernardo D. Inference of gene regulatory networks and compound mode of action from time course gene expression profiles. Bioinformatics 2006, 22:815-822.
127. Bonneau R. Learning biological networks: from modules to dynamics. Nat Chem Biol 2008, 4:658-664.
128. Miller-Jensen K, Janes KA, Brugge JS, Lauffenburger DA. Common effector processing mediates cell-specific responses to stimuli. Nature 2007, 448:604-608.
129. Janes KA, Albeck JG, Gaudet S, Sorger PK, Lauffenburger DA, et al. A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis. Science 2005, 310:1646-1653.
130. Gordus A, Krall JA, Beyer EM, Kaushansky A, Wolf-Yadlin A, et al. Linear combinations of docking affinities explain quantitative differences in RTK signaling. Mol Syst Biol 2009, 5:235.
131. Kumar N, Afeyan R, Kim HD, Lauffenburger DA. Multi-pathway model enables prediction of kinase inhibitor cross-talk effects on migration of Her2-overexpressing mammary epithelial cells. Mol Pharmacol 2008, 73:1668-1678.
132. Bonneau R, Reiss DJ, Shannon P, Facciotti M, Hood L, et al. The inferelator: an algorithm for learning parsimonious regulatory networks from systems-biology data sets de novo. Genome Biol 2006, 7:R36.
133. Bonneau R, Facciotti MT, Reiss DJ, Schmid AK, Pan M, et al. A predictive model for transcriptional control of physiology in a free living cell. Cell. 2007, 131:1354-1365.
134. Bansal M, Belcastro V, Ambesi-Impiombato A, di Bernardo D. How to infer gene networks from expression profiles. Mol Syst Biol 2007, 3:78.
135. Schafer J, Strimmer K. An empirical Bayes approach to inferring large-scale gene association networks. Bioinformatics 2005, 21:754-764.
136. Basso K, Margolin AA, Stolovitzky G, Klein U, Dalla-Favera R, et al. Reverse engineering of regulatory networks in human B cells. Nat Genet 2005, 37:382-390.
137. Hartemink AJ. Reverse engineering gene regulatory networks. Nat Biotechnol 2005, 23:554-555.
138. Friedman N. Inferring cellular networks using probabilistic graphicalmodels. Science 2004, 303:799-805.
139. Shmulevich I, Dougherty ER, Kim S, Zhang W. Probabilistic Boolean networks: a rule-based uncertainty model for gene regulatory networks. Bioinformatics 2002, 18:261-274.
140. Hashimoto RF, Kim S, Shmulevich I, Zhang W, Bittner ML, et al. Growing genetic regulatory networks from seed genes. Bioinformatics 2004, 20:1241-1247.
141. Pal R, Datta A, Bittner ML, Dougherty ER. Intervention in context-sensitive probabilistic Boolean networks. Bioinformatics 2005, 21:1211-1218.
142. Soranzo N, Bianconi G, Altafini C. Comparing association network algorithms for reverse engineering of large-scale gene regulatory networks: synthetic versus real data. Bioinformatics 2007, 23:1640-1647.
143. Yu J, Smith VA, Wang PP, Hartemink AJ, Jarvis ED. Advances to Bayesian network inference for generating causal networks from observational biological data. Bioinformatics 2004, 20:3594-3603.
144. Camacho D, Vera LP, Mendes P, Laubenbacher R. Comparison of reverse-engineering methods using an in silico network. Ann N Y Acad Sci 2007, 1115:73-89.
145. Margolin AA, Califano A. Theory and limitations of genetic network inference from microarray data. Ann N Y Acad Sci 2007, 1115:51-72.
146. Feist AM, Herrgard MJ, Thiele I, Reed JL, Palsson B. Reconstruction of biochemical networks in microbial organisms. Nat Rev Microbiol 2009, 7:129-143.
147. Francke C, Siezen RJ, Teusink B. Reconstructing the metabolic network of a bacterium from its genome. Trends Microbiol 2005, 13:550-558.
148. Reed JL, Famili I, Thiele I, Palsson BO. Towards multidimensional genome annotation. Nat Rev Genet 2006, 7:130-141.
149. Feist AM, Henry CS, Reed JL, Krummenacker M, Joyce AR, et al. A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information. Mol Syst Biol 2007, 3:121.
150. Feist AM, Scholten JCM, Palsson B, Brockman FJ, Ideker T. Modeling methanogenesis with a genomescale metabolic reconstruction of Methanosarcina barkeri. Mol Syst Biol 2006, 2:(2006.0004).
151. Herrgard MJ, Swainston N, Dobson P, Dunn WB, Arga KY, et al. A consensus yeast metabolic network reconstruction obtained from a community approach to systems biology. Nat Biotechnol 2008, 26:1155-1160.
152. Chavali AK, Whittemore JD, Eddy JA, Williams KT, Papin JA. Systems analysis of metabolism in the pathogenic trypanosomatid Leishmania major. Mol Syst Biol 2008, 4:177.
153. Duarte NC, Becker SA, Jamshidi N, Thiele I, MoML, et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Nat Acad Sci 2007, 104:1777-1782.
154. Ma H, Sorokin A, Mazein A, Selkov A, Selkov E, et al. The Edinburgh human metabolic network reconstruction and its functional analysis. Mol Syst Biol 2007, 3:135.
155. Hoffmann A, Levchenko A, Scott ML, Baltimore D. The Ikappa B-NF-kappa B signaling module: temporal control and selective gene activation. Science 2002, 298:1241-1245.
156. Papin JA, Hunter T, Palsson BO, Subramaniam S. Reconstruction of cellular signalling networks and analysis of their properties. Nat Rev Mol Cell Biol 2005, 6:99-111.
157. Papin JA, Palsson BO. Topological analysis of massbalanced signaling networks: a framework to obtain network properties including crosstalk. J Theor Biol 2004, 227:283-297.
158. Gianchandani EP, Papin JA, Price ND, Joyce AR, Palsson BO, et al. Matrix formalism to describe functional states of transcriptional regulatory systems. PLoS Comput Biol 2006, 2:e101.
159. Covert MW, Knight EM, Reed JL, Herrgard MJ, Palsson BO. Integrating high-throughput and computational data elucidates bacterial networks. Nature 2004, 429:92-96.
160. Price ND, Reed JL, Palsson BO. Genome-scale models of microbial cells: evaluating the consequences of constraints. Nat Rev Microbiol 2004, 2:886-897.
161. Vo TD, Greenberg HJ, Palsson BO. Reconstruction and functional characterization of the human mitochondrial metabolic network based on proteomic and biochemical data. J Biol Chem 2004, 279:39532-39540.
162. Thiele I, Price ND, Vo TD, Palsson BO. Candidate metabolic network states in human mitochondria: impact of diabetes, ischemia, and diet. J Biol Chem 2005, 280:11683-11695.
163. Price ND, Schellenberger J, Palsson BO. Uniform sampling of steady-state flux spaces: means to design experiments and to interpret enzymopathies. Biophys J 2004, 87:2172-2186.
164. Papin JA, Palsson BO. The JAK-STAT signaling network in the human B-cell: an extreme signaling pathway analysis. Biophys J 2004, 87:37-46.
165. Lee DS, Park J, Kay KA, Christakis NA, Oltvai ZN, et al. The implications of human metabolic network topology for disease comorbidity. Proc Nat Acad Sci 2008, 105:9880-9885.
166. Ma H, Goryanin I. Human metabolic network reconstruction and its impact on drug discovery and development. Drug Discov Today 2008, 13:402-408.
167. Shlomi T, Cabili MN, Herrgård MJ, Palsson B, Ruppin E. Network-based prediction of human tissue-specific metabolism. Nat Biotechnol 2008, 26:1003-1010.
168. Robey IF, Lien AD, Welsh SJ, Baggett BK, Gillies RJ. Hypoxia-inducible factor-1a and the glycolytic phenotype in tumors. Neoplasia 2005, 7:324-330.
169. Esteban MA, Maxwell PH. HIF, a missing link between metabolism and cancer. Nat Med 2005, 11:1047-1048.
170. Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008, 13:472-482.
171. Hsu PP, Sabatini DM. Cancer cell metabolism: warburg and beyond. Cell 2008, 134:703-707.
172. Galmarini CM, Popowycz F, Joseph B. Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy. Curr Med Chem 2008, 15:1072-1082.
173. Serkova NJ, Spratlin JL, Eckhardt SG. NMRbased metabolomics: translational application and treatment of cancer. Curr Opin Mol Ther 2007, 9:572-585.
174. Robak T, Lech-Maranda E, Korycka A, Robak E. Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity. Curr Med Chem 2006, 13:3165-3189.
175. Werner SL, Barken D, Hoffmann A. Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 2005, 309:1857-1861.
176. Segre D, Zucker J, Katz J, Lin X, D'Haeseleer P, et al. From annotated genomes to metabolic flux models and kinetic parameter fitting. OMICS 2003, 7:301-316.
177. Aldridge BB, Burke JM, Lauffenburger DA, Sorger PK. Physicochemical modelling of cell signalling pathways. Nat Cell Biol 2006, 8:1195-1203.
178. Kholodenko BN. Cell-signalling dynamics in time and space. Nat Rev Mol Cell Biol 2006, 7:165-176.
179. Covert MW, Leung TH, Gaston JE, Baltimore D. Achieving stability of lipopolysaccharide-induced NFkappaB activation. Science 2005, 309:1854-1857.
180. Geva-Zatorsky N, Rosenfeld N, Itzkovitz S, Milo R, Sigal A, et al. Oscillations and variability in the p53 system. Mol Syst Biol 2006, 2:2006.0033.
181. Ma L, Wagner J, Rice JJ, Hu W, Levine AJ, et al. A plausible model for the digital response of p53 to DNA damage. Proc Natl Acad Sci USA 2005, 102:14266-14271.
182. Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 2005, 4:988-1004.
183. Asthagiri AR, Lauffenburger DA. A computational study of feedback effects on signal dynamics in a mitogen-activated protein kinase (MAPK) pathway model. Biotechnol Prog 2001, 17:227-239.
184. Brightman FA, Fell DA. Differential feedback regulation of the MAPK cascade underlies the quantitative differences in EGF and NGF signalling in PC12 cells. FEBS Lett 2000, 482:169-174.
185. Schoeberl B, Eichler-Jonsson C, Gilles ED, Muller G. Computational modeling of the dynamics of theMAP kinase cascade activated by surface and internalized EGF receptors. Nat Biotechnol 2002, 20:370-375.
186. Christopher R, Dhiman A, Fox J, Gendelman R, Haberitcher T, et al. Data-driven computer simulation of human cancer cell. Ann N Y Acad Sci 2004, 1020:132-153.
187. Li H, Fan X, Houghton J. Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem 2007, 101:805-815.
188. Bellomo N, Preziosi L. Modelling and mathematical problems related to tumor evolution and its interaction with the immune system. Math Comput Model 2000, 32:413-452.
189. Araujo RP, McElwain DL. A history of the study of solid tumour growth: the contribution of mathematical modelling. Bull Math Biol 2004, 66:1039-1091.
190. Araujo RP, McElwain DLS. A history of the study of solid tumour growth: the contribution of mathematical modelling. Bull Math Biol 2004, 66:1039-1091.
191. Quaranta V, Rejniak KA, Gerlee P, Anderson AR. Invasion emerges from cancer cell adaptation to competitive microenvironments: quantitative predictions from multiscale mathematical models. Semin Cancer Biol 2008, 18:338-348.
192. Alarcón T, Byrne HM, Maini PK. A mathematical model of the effects of hypoxia on the cell-cycle of normal and cancer cells. J Theor Biol 2004, 229:395-411.
193. Ambrosi D, Mollica F. The role of stress in the growth of a multicell spheroid. J Math Biol 2004, 48:477-499.
194. Anderson ARA. A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion. Math Med Biol 2005, 22:163-186.
195. Johnston MD, Edwards CM, Bodmer WF, Maini PK, Chapman SJ. Mathematical modeling of cell population dynamics in the colonic crypt and in colorectal cancer. Proc Nat Acad Sci 2007, 104:4008.
196. d'Onofrio A, Tomlinson IPM. A nonlinear mathematical model of cell turnover, differentiation and tumorigenesis in the intestinal crypt. J Theor Biol 2007, 244:367-374.
197. Byrne H, Preziosi L. Modelling solid tumour growth using the theory of mixtures. Math Med Biol 2003, 20:341-366.
198. Breward CJW, Byrne HM, Lewis CE. The role of cellcell interactions in a two-phase model for avascular tumour growth. J Math Biol 2002, 45:125-152.
199. Macklin P, Lowengrub J. Nonlinear simulation of the effect of microenvironment on tumor growth. J Theor Biol 2007, 245:677-704.
200. Alarcon T, Byrne HM, Maini PK. A multiple scale model for tumor growth. Multiscale Model Simul 2005, 3:440-475.
201. Spencer SL, Berryman MJ, García JA, Abbott D. An ordinary differential equation model for the multistep transformation to cancer. J Theor Biol 2004, 231:515-524.
202. Baum M, Chaplain MAJ, Anderson ARA, Douek M, Vaidya JS. Does breast cancer exist in a state of chaos? Eur J Cancer 1999, 35:886-891.
203. Rew DA. Tumour biology, chaos and non-linear dynamics. Eur J Surg Oncol 1999, 25:86-89.
204. Deisboeck TS, Yoon J, Costa J. In silico cancer modeling: is it ready for prime time? Nat Clin Pract Oncol 2008, 6:34-42.
205. Mansury Y, Kimura M, Lobo J, Deisboeck TS. Emerging patterns in tumor systems: simulating the dynamics of multicellular clusters with an agent-based spatial agglomeration model. J Theor Biol 2002, 219:343-370.
206. Little MP, Vineis P, Li G. A stochastic carcinogenesis model incorporating multiple types of genomic instability fitted to colon cancer data. J Theor Biol 2008, 254:229-238.
207. Dingli D, Traulsen A, Pacheco JM. Stochastic dynamics of hematopoietic tumor stem cells. Cell Cycle 2007, 6:461-466.
208. Ostby I, Oyehaug L, Steen HB. A stochastic model of cancer initiation including a bystander effect. J Theor Biol 2006, 241:751-764.
209. Kansal AR, Torquato S, Harsh Iv GR, Chiocca EA, Deisboeck TS. Simulated brain tumor growth dynamics using a three-dimensional cellular automaton. J Theor Biol 2000, 203:367-382.
210. Mallet DG, De Pillis LG. A cellular automata model of tumor-immune system interactions. J Theor Biol 2006, 239:334-350.
211. Alarcín T, Byrne HM, Maini PK. A cellular automaton model for tumour growth in inhomogeneous environment. J Theor Biol 2003, 225:257-274.
212. Bauer AL, Jackson TL, Jiang Y. A cell-based model exhibiting branching and anastomosis during tumor-induced angiogenesis. Biophys J 2007, 92:3105-3121.
213. Patel AA, Gawlinski ET, Lemieux SK, Gatenby RA. A cellular automaton model of early tumor growth and invasion: the effects of native tissue vascularity and increased anaerobic tumor metabolism. J Theor Biol 2001, 213:315-331.
214. Mansury Y, Deisboeck TS. The impact of "search precision" in an agent-based tumor model. J Theor Biol 2003, 224:325-337.
215. McDougall SR, Anderson ARA, Chaplain MAJ. Mathematicalmodelling of dynamic adaptive tumourinduced angiogenesis: clinical implications and therapeutic targeting strategies. J Theor Biol 2006, 241:564-589.
216. Anderson AR. A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion. Math Med Biol 2005, 22:163-186.
217. Zhang L, Athale CA, Deisboeck TS. Development of a three-dimensional multiscale agent-based tumor model: simulating gene-protein interaction profiles, cell phenotypes and multicellular patterns in brain cancer. J Theor. Biol 2007, 244:96-107.
218. Anderson AR, Weaver AM, Cummings PT, Quaranta V. Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 2006, 127:905-915.
219. Ohno R, Nakamura Y. Prediction of response to imatinib by cDNA microarray analysis. Semin Hematol 2003, 42-49.